DRUG-PATHWAY

DRUGs and PATHWAYs

PATHWAY_NAME	REACTOME_ID	KEGG_ID	DRUG_NAME	PUBCHEM_CID	Datasource
Autoimmune thyroid disease	R-HSA-1643685	map05320	tranylcypromine	19493	drug-path
Olfactory transduction	R-HSA-9751605	map04740	tranylcypromine	19493	drug-path
Cell adhesion molecules (CAMs)	R-HSA-1031690	0	tranylcypromine	19493	drug-path
Systemic lupus erythematosus	R-HSA-977105	map05322	tranylcypromine	19493	drug-path
Non-small cell lung cancer	R-HSA-5619066	map05223	tranylcypromine	19493	drug-path
Gap junction	R-HSA-190861	map04540	tranylcypromine	19493	drug-path
Allograft rejection	R-HSA-9679028	map05330	tranylcypromine	19493	drug-path
Type I diabetes mellitus	R-HSA-5683209	map04940	tranylcypromine	19493	drug-path
Focal adhesion	R-HSA-354113	map04510	tranylcypromine	19493	drug-path
Regulation of actin cytoskeleton	R-HSA-392751	map04810	tranylcypromine	19493	drug-path
Graft-versus-host disease	R-HSA-1643685	map05332	chlorzoxazone	4032	drug-path
Hematopoietic cell lineage	R-HSA-173752	map04640	chlorzoxazone	4032	drug-path
Autoimmune thyroid disease	R-HSA-1643685	map05320	chlorzoxazone	4032	drug-path
Shigellosis	0	map05131	chlorzoxazone	4032	drug-path
Pathogenic Escherichia coli infection	R-HSA-9609646	map05130	chlorzoxazone	4032	drug-path
Olfactory transduction	R-HSA-9751605	map04740	chlorzoxazone	4032	drug-path
Asthma	R-HSA-444620	map05310	chlorzoxazone	4032	drug-path
Gap junction	R-HSA-190861	map04540	chlorzoxazone	4032	drug-path
Allograft rejection	R-HSA-9679028	map05330	chlorzoxazone	4032	drug-path
Neuroactive ligand-receptor interaction	R-HSA-5632681	map04080	chlorzoxazone	4032	drug-path